RT Journal Article T1 High-affinity A/T-rich DNA binding with a dimeric bisbenzamidine A1 Bouzada Reboredo, David A1 Paul, Ananya A1 Sánchez López, Mateo Isidro A1 Domínguez-Asenjo, Bárbara A1 Lence Quintana, Emilio José A1 Melle-Franco, Manuel A1 Ardá, Ana A1 Barreiro Piñeiro, Natalia A1 Penas, Cristina A1 Gómez González, Jacobo A1 Jiménez-Barbero, Jesús A1 Moreno, Javier A1 González Bello, Concepción A1 Wilson, W. David A1 Mascareñas Cid, José Luis A1 Vázquez Sentís, Marco Eugenio K1 Dimeric bisbenzamidine K1 ADN K1 A/T AB A bisbenzamidine DNA binding agent can be easily dimerized by alkylation of its terminal amidine groups to afford an extended minor groove binder with over 20-fold enhanced DNA affinity toward extended A/T-rich sites. Nuclear magnetic resonance experiments in combination with molecular dynamics simulation studies provide structural insight into the insertion of this compound in the DNA minor groove, and antimicrobial assays demonstrate that the increased affinity translates into higher antileishmanial activity. PB Oxford Academic SN 2976-856X YR 2024 FD 2024 LK https://hdl.handle.net/10347/40115 UL https://hdl.handle.net/10347/40115 LA eng NO Bouzada, D., Paul, A., Sánchez, M. I., Domínguez-Asenjo, B., Lence, E., Melle-Franco, M., Ardá, A., Barreiro-Piñeiro, N., Penas, C., Gómez-González, J., Jiménez-Barbero, J., Moreno, J., González-Bello, C., Wilson, W. D., Mascareñas, J. L., & Vázquez, M. E. (2024). High-affinity A/T-rich DNA binding with a dimeric bisbenzamidine. NAR Molecular Medicine, 1(4), Article ugae022 . https://doi.org/10.1093/narmme/ugae022 NO Agencia Estatal de Investigación [RTI2018-099877-B-I00, PID2022-136963OB-I00, PID2021-127702NB-I00]; Xunta de Galicia [ED431C 2021/29, ED431G 2023/03]; European Regional Development Fund; CICECO [IF/00894/2015, UIDB/50011/2020, UIDP/50011/2020, LA/P/0006/2020]; EDCTP [RIA2020S-3301]; ISCIII [PI21CIII/00005]; CIBERINFEC [CB21/13/00018]. DS Minerva RD 22 abr 2026